Serotonin (5-HT) binding sites from bovine and rat cerebral cortex membranes share pharmacological properties that allow both to be subclassified by the same criteria. We show here that [3Hj5-HT binding sites from human cortex also possess pharmacological properties that follow the same subclassification scheme as for bovine and rat cortex. In addition, we show that solubilized 5-HT1 and 5-HT3 sites from all three species have an s20,w value of 3.4. Despite these similar pharmacological and physical characteristics, we can demonstrate antigenic differences between receptor types and spe- (refs. 3 and 4; unpublished data). In an effort to maintain consistency in nomenclature, we will refer to this last site as a 5-HT3 type. We have also solubilized the 5-HT1 and 5-HT3 sites from bovine cortex and described their biophysical characteristics (3).
sites possess nanomolar affinity for 5-HT and micromolar affinity for spiperone and ketanserin. 5-HT2 binding sites have micromolar affinity for 5-HT and nanomolar affinity for spiperone and ketanserin. Recent evidence from our laboratory (3) and from Fillion et al. (4) 3 and 4; un- published data). In an effort to maintain consistency in nomenclature, we will refer to this last site as a 5-HT3 type. We have also solubilized the 5-HT1 and 5-HT3 sites from bovine cortex and described their biophysical characteristics (3) .
In the course of a study on hyperserotonemia in autistic children, we found a child with circulating antibodies directed against human cortical 5-HT binding sites. Further investigation disclosed that these antibodies cross-reacted only with the 5-HT1A subclass of 5-HT1 binding sites. This gave us the opportunity to study antigenic properties ofthe class of binding sites across species. In this report, we compare the properties of 5-HT1 and 5-HT3 sites from human, rat, and bovine cortex, describe the characterization of the antibodies from the autistic child, and demonstrate intra-and interspecies differences in antigenicity in 5-HT binding sites.
MATERIALS AND METHODS
The child reported here is a 9-year-old girl who was in good health and free of all medications at the time of the study. She met DSM-III (5) criteria for infantile autism, as determined by three independent, experienced clinical evaluators. Venous blood samples were collected into EDTA-containing tubes. Platelet 5-HT as measured by the method of Stahl et al. (6) was 72 ng per 108 platelets or 550 ng/ml of whole blood. IgG class antibodies were purified from serum samples by protein A-Sepharose 4B (Sigma) affinity chromatography (7) . Greater than 85% of serum IgG was recovered in one column passage. Human frontal cortex tissue was obtained at autopsy. Membranes from human, bovine, or rat cortex were prepared as described (3) . Gel electrophoresis was performed on 10% acrylamide/0.1% sodium dodecyl sulfate slab gels. Coomassie blue staining and densitometry were carried out as described (8) . High molecular weight standards (Sigma) were electrophoresed for molecular weight determinations. The agarose IgG fraction of goat antihuman IgG was obtained from Miles-Yeda (Rehovot, Israel).
Samples were analyzed for [3H]5-HT binding by equilibrium saturation (Scatchard) analysis (9) as described (3), except as follows: membrane samples were incubated with and without purified antibodies for 20 min at 30°C and then placed on ice for 2 hr. The equivalent serum dilution was 1:3 in all cases.
[3H]5-HT (0.5-200 nM, 28 Ci/mmol; 1 Ci = 37
GBq; New England Nuclear) and 10 AM pargyline were then added to aliquots of membranes containing 80 ,kg of protein, with or without added IgG, in duplicate and incubated for a further 20 min at 30°C. Samples were then placed on ice, filtered, and assayed for radioactivity as described (3) . Specifically bound radioactivity was determined by the addition of 10 or 100 ,uM 5-HT to equivalent assay tubes (3). Saturation curves were resolved into two components by computer analysis and separate affinity constants (Kd) and site concentrations (Bmax) were determined (3). Minimal antibody titers were calculated by determining the absolute reduction in Bmax. of a particular binding site per ml of serum. This probably underestimates the actual titer of antireceptor antibody since only antibodies that block [3H]5-HT binding are detected.
A sample of cerebrospinal fluid (CSF) was obtained from a lumbar puncture of the child done as part of another study (consent of parents obtained). CSF was dialyzed against 50 mM Tris-HCl (pH 7.4) and used directly in assays or pretreated with agarose-linked goat anti-human IgG antibody to remove human IgG.
5-HT1 and 5-HT3 receptors were solubilized as described elsewhere, except that 3% Triton X-100 and 1% Tween-80 were used (3). Sedimentation coefficients (s20,w) were estimated by comparison with the sedimentation of bovine serum albumin (s20o, = 4.6) on 10-30% glycerol gradients containing detergent (3). Glycerol gradient sedimentation of solubilized membranes from human (B), bovine (A), and rat (C) origin. Three-hundred-microliter aliquots of membranes solubilized with 3% Triton X-100 and 1% Tween-80 (3) were layered onto 5 ml of 10-30%o glycerol gradients containing 0.3% Triton X-100, 0.1% Tween.80, and 50 mM Tris HCl (pH 6.9). Gradients were spun at 35,000 rpm in an SW 39 rotor for 48 hr. Samples were collected from the bottom of each tube and 20-id aliquots were assayed for [3H]5-HT binding (3). Gradients shown were from a single centrifugation. The calculated S20, was 3.4 0.4 for two centrifuge runs. This value compares well with our previously reported value of 3.5 0.3 (SEM, n = 7) for bovine cortex (3) . from the autistic girl, there is a decrease in the 5-HT1 component of the Scatchard curve (Fig. 3A, open circles) (Fig. 4A) well (Fig. 4B) cies in other antigenic domains that would not have been detected by the assay method used here.
DISCUSSION
The results in this report describe the discovery of autoantibodies against 5-HT binding proteins present in the blood and CSF of an autistic child. These antibodies are of the IgG class, discriminate between 5-HT1A and other 5-HT binding proteins, and are specific for human 5-HT1A sites. Use of them, even in the limited way described here, has provided helpful insights into structural similarities and differences among 5-HT binding proteins.
Antibodies against nicotinic cholinergic receptors have played a major role in elucidating the structure of these proteins, their subunit relationships, and their position in cell membranes (see ref. 14 for review). In addition, there appears to be at least one clinical disorder in humans, myasthenia gravis, in which autoantibodies exist against nicotinic receptors (13) .
The characterization and classification of other neurotransmitter receptors have been difficult and at times confusing. Pharmacologic characterization has been widely employed to differentiate neurotransmitter receptors, but the applicability of this procedure is limited by the lack of specificity of most available ligands. Antibodies Fig. 2 ) characteristics of these sites are similar. Presumably, some as yet undetermined structural differences exist. The functional significance of these differences remains to be shown. It is conceivable that the antigenic sites recognized by this child's antibodies are directed against associated membrane components that are species specific and that the binding proteins themselves are identical. The testing of this hypoth-
